Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

NYSE:RDY

Dr. Reddy's Laboratories Limited

Last Close

74.55

29/04 20:00

Market Cap

12.41B

Beta: 0.24

Volume Today

198.00K

Avg: 213.67K

PE Ratio

19.34

PFCF: 35.19

Dividend Yield

0.02%

Payout:12.73%

Please Sign In To Use The Chat